Main > NEUROLOGY. > Parkinsons Disease > Treatment > Retinal Pigment Epithelium Cells > Co.: USA. T (Development/Patents)

---

Co.: USA. T (Development/Patents)'s subsections
Advanced Parkinson s Disease
Clinical Status: Phase IIB
Collagen Coat. Dextran MicroCarrier
Company
Delivery: Stereotactic Injection
FDA - Fast Track Designation
FDA - Orphan Drug Designation
Partner Company
Patent
Pilot Clinical Study + Results
Technology
TradeMark
UpDate: 12.15.05
Web-Site

Co.: USA. T (Development/Patents)'s products
This section has no products